BioSpace News Archive

Avidity Biosciences, a biotechnology company pioneering Antibody-Oligonucleotide Conjugates (AOCs™) focused in rare muscle disorders and other serious diseases, today announced the appointment of Noreen Henig, M.D., and Edward Kaye, M.D., to the company’s board of directors.

The Maximum Tender Offer for the 2020 Maximum Tender Offer Notes is referred to as the “2020 Notes Maximum Tender Offer” and the Maximum Tender Offer for the 2021 Maximum Tender Offer Notes is referred to as “2021 Notes Maximum Tender Offer”.

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that clinical data highlighting real-world performance of the Company’s Target Selector™ platform for detecting actionable biomarkers in lung cancer patients will be presented at the 2019 IASLC World Conference on Lung Cance

Theragun, the leader in percussive therapy, announced the opening of Theragun Reset™ in Los Angeles, the world’s first-ever brick and mortar percussive therapy experience.

Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions, including adherence tools for pharmacies, healthcare systems, and health plans, will roll out its vision of the Autonomous Pharmacy to retail pharmacies during the National Association of Chain Drug Stores (NACDS) Total Store Expo, taking place at the Boston Convention Center on August 24-26, 2019.

CrossBay Medical, Inc., today announced that it has received clearance to commercialize its product, the Endometrial Tissue Sampler using CrossGlide™ technology, in Europe by obtaining its CE Mark.

VentureSouth Leads Group of Investors in Groundbreaking Infectious Disease Identification Technology

AmerisourceBergen, a global healthcare solutions leader, is expanding access to its Opioid Assistance Pilot Program to all full-time associates and their dependents in Texas, South Carolina, North Carolina, and Pennsylvania who are enrolled in a company-sponsored medical plan.

Patients, Whether Insured or Not, Can Pay Less Than $50 to Purchase an Over-the-Counter Telemedicine Visit to Receive Treatment in Under 30 Minutes

The Hazelden Betty Ford Foundation announced today the expansion of its Patient Care Network—the first of its kind in the addiction treatment industry—to include CentraCare, a Minnesota-based health system serving central, west central and southwest Minnesota.